Re:AstraZeneca unveils successes in treatment of lung cancer
by pauln99 on Monday February 19, 2024 @02:12PM
(#39433491)
To be clear, those aren't 16 years of accumulating improvements. The median life extension - across all 90-odd drugs - was two months.
Re:AstraZeneca unveils successes in treatment of lung cancer
by s1artibartfast on Monday February 19, 2024 @02:35PM
(#39433729)
I understand that specifically is for stage 4 non small cell lung cancer, but I don't think it's appropriate to cherry pick a single example. There are other cancers and stages we're much more progress has been made.
That 2 months average is often driven by more people alive at the end of a 2 year trial.
Also, 16 years of 2 month extensions ends up being quite meaningful.